Plain-English translation of NCT07370389 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a medication called tulodsesvenlafaxine can help reduce the pain of shingles when used alongside standard treatments. Shingles causes a painful rash and can lead to ongoing nerve pain that doesn't respond well to common pain medications. Researchers believe this medication, which is an antidepressant, may work differently to help calm pain signals in the brain and nervous system.
Many people with shingles experience moderate to severe pain that doesn't improve enough with standard painkillers, and some go on to develop chronic nerve pain that lasts for months or years. This medication works on pain pathways in the brain in a different way than typical pain relievers, so researchers want to see if adding it to standard treatment can help more patients get better relief.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would take the new medication by mouth in addition to your standard shingles treatment. You would likely need to visit the study clinic multiple times so researchers can track how your pain improves and watch for any side effects. The study involves 750 participants total, and you would be compared with other patients to see whether adding this medication makes a real difference in pain relief.
AI-generated summary from trial data · Sep 5, 2026 · Not medical advice
China